ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET FORECAST 2017-2025
KEY FINDINGS
Asia-Pacific Single cell analysis market is estimated to grow at a CAGR of 20.12 % for the forecast year of 2017-2025 and is anticipated to generate a revenue of about $1530 million by the year 2025. Asia Pacific is anticipated to be the fastest growing market during the forecast period because of the increasing technological advancement and booming biotechnology and biopharmaceutical industries.
MARKET INSIGHTS
The Asia-Pacific market geography consists of countries like India, China, Australia, Japan and the Rest of Asia Pacific. The market potential in the Asia-Pacific region is mainly a result of a developing need for stem cell therapies for the treatment owing to increasing number of patient population and prevalence of chronic lifestyle diseases. An increase in the government funding for research, rising potential in single-cell DNA and RNA analysis and increasing occurrence of infectious diseases are the major factors contributing to the growth of the market.
COMPETITIVE INSIGHTS
The major players in the Single-cell analysis market are Thermo Fisher Scientific Inc, GE Healthcare, Beckman colter Inc, Beckton Dickinson and company, Stem Cell Technologies, Stryker Corporation, Medtronic’s plc, Miltenyi Biotec, Celgene Corporation, Nanostring Technologies Inc, and Agilent Technology Inc. GE Healthcare has the major market share in the single cell market as compared to rest of the companies.
Asia-Pacific Single cell analysis market is estimated to grow at a CAGR of 20.12 % for the forecast year of 2017-2025 and is anticipated to generate a revenue of about $1530 million by the year 2025. Asia Pacific is anticipated to be the fastest growing market during the forecast period because of the increasing technological advancement and booming biotechnology and biopharmaceutical industries.
MARKET INSIGHTS
The Asia-Pacific market geography consists of countries like India, China, Australia, Japan and the Rest of Asia Pacific. The market potential in the Asia-Pacific region is mainly a result of a developing need for stem cell therapies for the treatment owing to increasing number of patient population and prevalence of chronic lifestyle diseases. An increase in the government funding for research, rising potential in single-cell DNA and RNA analysis and increasing occurrence of infectious diseases are the major factors contributing to the growth of the market.
COMPETITIVE INSIGHTS
The major players in the Single-cell analysis market are Thermo Fisher Scientific Inc, GE Healthcare, Beckman colter Inc, Beckton Dickinson and company, Stem Cell Technologies, Stryker Corporation, Medtronic’s plc, Miltenyi Biotec, Celgene Corporation, Nanostring Technologies Inc, and Agilent Technology Inc. GE Healthcare has the major market share in the single cell market as compared to rest of the companies.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM- UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS
4.1.1. EXPANDING TECHNOLOGICAL INNOVATIONS
4.1.2. EXPANDING OCCURRENCE OF TRANSMITTABLE INFECTIONS ACROSS THE GLOBE
4.1.3. GROWING AGED POPULACE
4.1.4. GROWING BIOPHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
4.1.5. RISING GOVERNMENT SUBSIDY FOR RESEARCH
4.2. RESTRAINTS
4.2.1. LARGE PRIMARY COST DISCOURAGING INVESTMENT
4.2.2. CONCERNS ASSOCIATED WITH INTELLECTUAL PROPERTY AND PATENTS RIGHTS
4.3. MARKET OPPORTUNITY
4.3.1. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.2. DEVELOPMENT OF INNOVATIVE MODALITIES
4.3.3. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.4. INCREASING INVESTMENT MADE BY THE ASIAN COUNTRIES
4.3.5. ENHANCE OPPORTUNITY IN CANCER CELL RESEARCH
4.4. CHALLENGES
4.4.1. LACK OF ADEQUATE INFRASTRUCTURE
4.4.2. DELAYED ADOPTION OF SINGLE CELL TECHNOLOGY
5. MARKET SEGMENTATION
5.1. BY APPLICATION
5.1.1. MEDICAL APPLICATIONS MARKET
5.1.1.1. CIRCULAR TUMOUR CELLS (CTCS) MARKET
5.1.1.2. NON-INVASIVE PRENATAL DIAGNOSIS MARKET
5.1.1.3. IN VITRO FERTILIZATION (IVF) MARKET
5.1.2. RESEARCH APPLICATIONS MARKET
5.1.2.1. CANCER MARKET
5.1.2.2. IMMUNOLOGY MARKET
5.1.2.3. NEUROLOGY MARKET
5.1.2.4. STEM CELLS MARKET
5.1.2.5. OTHER RESEARCH APPLICATIONS MARKET
5.2. BY TECHNIQUE
5.2.1. FLOW CYTOMETRY MARKET
5.2.2. MASS SPECTROMETRY MARKET
5.2.3. MICROSCOPY MARKET
5.2.3.1. NEXT-GENERATION SEQUENCING (NGS) MARKET
5.2.3.2. PCR (POLYMERASE CHAIN REACTION) MARKET
5.2.3.3. OTHER TECHNIQUES MARKET
5.3. BY CELL TYPE
5.3.1. ANIMAL CELLS MARKET
5.3.2. HUMAN CELLS MARKET
5.3.3. MICROBIAL CELLS MARKET
5.4. BY END USER
5.4.1. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET
5.4.2. CELL BANKS AND IVF CENTERS MARKE
5.4.3. HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET
5.4.4. RESEARCH & ACADEMIC LABORATORIES MARKET
5.5. BY PRODUCT
5.5.1. CONSUMABLE MARKET
5.5.1.1. ASSAY KITS MARKET
5.5.1.2. BEADS MARKET
5.5.1.3. MICRO PLATES MARKET
5.5.1.4. REAGENTS MARKET
5.5.1.5. OTHER CONSUMABLES MARKET
5.5.2. INSTRUMENT MARKET
5.5.2.1. CELL COUNTER MARKET
5.5.2.2. CELL MICROARRAYS MARKET
5.5.2.3. FLOW CYTOMETERS MARKET
5.5.2.4. HCS SYSTEMS MARKET
5.5.2.5. MICROSCOPES
5.5.2.6. OTHER INSTRUMENTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCT
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.4.4. APPLICATION AND EFFECTIVENESS
6.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET
7.1.1. INDIA SINGLE CELL ANALYSIS MARKET
7.1.2. CHINA SINGLE CELL ANALYSIS MARKET
7.1.3. JAPAN SINGLE CELL ANALYSIS MARKET
7.1.4. AUSTRALIA SINGLE CELL ANALYSIS MARKET
7.1.5. ROAPAC SINGLE CELL ANALYSIS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. TOP WINNING STRATEGIES
9. COMPANY PROFILES
9.1. CORNING INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. CELGENE CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. ILLUMINA INC.
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVE
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. MILTENYI BIOTEC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT ANALYSIS
9.4.5. STRATEGIC ANALYSIS
9.5. NANOSTRING TECHNOLOGIESINC
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVE
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. AGILENT TECHNOLOGY INC
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. GE HEALTHCARE
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. BECKMAN COULTER, INC.
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. SCOT ANALYSIS
9.8.4. STRATEGIC ANALYSIS
9.9. MEDTRONIC’S PLC
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVE
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. STRYKER CORPORATION
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. THERMO FISHER SCIENTIFIC, INC.
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVE
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. QIAGEN N V
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT ANALYSIS
9.12.4. STRATEGIC ANALYSIS
9.13. BECKTON DICKINSON AND COMPANY
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. SCOT ANALYSIS
9.13.4. STRATEGIC ANALYSIS
9.14. STEM CELL TECHNOLOGIES
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES
9.14.4. SCOT ANALYSIS
9.14.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY APPLICATION 2017-2025($ MILLION)
TABLE 2 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2017-2025($ MILLION)
TABLE 3 ASIA-PACIFIC CTCS MARKET 2017-2025($ MILLION)
TABLE 4 ASIA-PACIFIC NIPT MARKET 2017-2025($ MILLION)
TABLE 5 ASIA-PACIFIC IVF MARKET 2017-2025($ MILLION)
TABLE 6 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS 2017-2025($ MILLION)
TABLE 7 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS 2017-2025($ MILLION)
TABLE 8 ASIA-PACIFIC CANCER MARKET 2017-2025($ MILLION)
TABLE 9 ASIA-PACIFIC IMMUNOLOGY MARKET 2017-2025($ MILLION)
TABLE 10 ASIA-PACIFIC NEUROLOGY MARKET 2017-2025($ MILLION)
TABLE 11 ASIA-PACIFIC STEM CELLS MARKET 2017-2025($ MILLION)
TABLE 12 ASIA-PACIFIC OTHER RESEARCH APPLICATIONS MARKET 2017-2025($ MILLION)
TABLE 13 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY TECHNIQUE 2017-2025($ MILLION)
TABLE 14 ASIA-PACIFIC FLOW CYTOMETRY MARKET 2017-2025($ MILLION)
TABLE 15 ASIA-PACIFIC MASS SPECTROMETRY MARKET 2017-2025($ MILLION)
TABLE 16 ASIA-PACIFIC MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 17 ASIA-PACIFIC MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 18 ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET 2017-2025($ MILLION)
TABLE 19 ASIA-PACIFIC PCR MARKET 2017-2025($ MILLION)
TABLE 20 ASIA-PACIFIC OTHER TECHNIQUES MARKET 2017-2025($ MILLION)
TABLE 21 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2017-2025($ MILLION)
TABLE 22 ASIA-PACIFIC ANIMAL CELL MARKET BY REGION 2017-2025($ MILLION)
TABLE 23 ASIA-PACIFIC HUMAN CELL MARKET 2017-2025($ MILLION)
TABLE 24 ASIA-PACIFIC MICROBIAL CELL MARKET 2017-2025($ MILLION)
TABLE 25 ASIA-PACIFIC BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
TABLE 26 ASIA-PACIFIC CELL BANKS AND IVF CENTERS MARKET 2017-2025($ MILLION)
TABLE 27 ASIA-PACIFIC HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 28 ASIA-PACIFIC RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 29 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY PRODUCTS 2017-2025($ MILLION)
TABLE 30 ASIA-PACIFIC SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 31 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
TABLE 32 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
TABLE 33 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
TABLE 34 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY REAGENTS 2017-2025($ MILLION)
TABLE 35 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
TABLE 36 ASIA-PACIFIC SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 37 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
TABLE 38 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
TABLE 39 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
TABLE 40 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
TABLE 41 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE LIST
FIGURE 1 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 2 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 3 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CTCS 2017-2025($ MILLION)
FIGURE 4 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY NIPT 2017-2025($ MILLION)
FIGURE 5 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY IVF 2017-2025($ MILLION)
FIGURE 6 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CANCER 2017-2025($ MILLION)
FIGURE 7 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY IMMUNOLOGY 2017-2025($ MILLION)
FIGURE 8 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY NEUROLOGY 2017-2025($ MILLION)
FIGURE 9 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY STEM CELLS 2017-2025($ MILLION)
FIGURE 10 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER RESEARCH APPLICATIONS 2017-2025($ MILLION)
FIGURE 11 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 12 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MASS SPECTROMETRY 2017-2025($ MILLION)
FIGURE 13 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROSCOPY 2017-2025($ MILLION)
FIGURE 14 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY NEXT GENERATION SEQUENCING 2017-2025($ MILLION)
FIGURE 15 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY PCR 2017-2025($ MILLION)
FIGURE 16 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER TECHNIQUES 2017-2025($ MILLION)
FIGURE 17 ASIA-PACIFIC ANIMAL CELL MARKET 2017-2025($ MILLION)
FIGURE 18 ASIA-PACIFIC HUMAN CELL MARKET 2017-2025($ MILLION)
FIGURE 19 ASIA-PACIFIC NEW CANCER CASES AND MOTILITY RATE IN MILLION (2015-2030)
FIGURE 20 ASIA-PACIFIC MICROBIAL CELL MARKET 2017-2025($ MILLION)
FIGURE 21 ASIA-PACIFIC BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
FIGURE 22 ASIA-PACIFIC CELL BANKS AND IVF CENTERS MARKET
FIGURE 23 ASIA-PACIFIC HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 24 ASIA-PACIFIC RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 25 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
FIGURE 26 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
FIGURE 27 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
FIGURE 28 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY REGENTS 2017-2025($ MILLION)
FIGURE 29 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
FIGURE 30 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
FIGURE 31 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
FIGURE 32 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 33 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY HCS SYSTEM 2017-2025($ MILLION)
FIGURE 34 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
FIGURE 35 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE 36 HEALTH REPORT OF INDIA ACCORDING 2015 SCENARIO
FIGURE 37 INDIAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 38 NUMBER OF CASES OF LUNG CANCERSTATISTICS IN CHINA (2010-2015)
FIGURE 39 CHINA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 40 JAPAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 41 ESTIMATED TB INCIDENCE BY AGE AND SEX (THOUSANDS), 2015 (AUSTRALIA)
FIGURE 42 AUSTRALIA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 43 RO APAC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM- UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
4. MARKET OVERVIEW
4.1. DRIVERS
4.1.1. EXPANDING TECHNOLOGICAL INNOVATIONS
4.1.2. EXPANDING OCCURRENCE OF TRANSMITTABLE INFECTIONS ACROSS THE GLOBE
4.1.3. GROWING AGED POPULACE
4.1.4. GROWING BIOPHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
4.1.5. RISING GOVERNMENT SUBSIDY FOR RESEARCH
4.2. RESTRAINTS
4.2.1. LARGE PRIMARY COST DISCOURAGING INVESTMENT
4.2.2. CONCERNS ASSOCIATED WITH INTELLECTUAL PROPERTY AND PATENTS RIGHTS
4.3. MARKET OPPORTUNITY
4.3.1. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.2. DEVELOPMENT OF INNOVATIVE MODALITIES
4.3.3. SINGLE-CELL SEQUENCING (SCS) PROCESS BEING INCREASING USED IN DNA AND RNA ANALYSIS
4.3.4. INCREASING INVESTMENT MADE BY THE ASIAN COUNTRIES
4.3.5. ENHANCE OPPORTUNITY IN CANCER CELL RESEARCH
4.4. CHALLENGES
4.4.1. LACK OF ADEQUATE INFRASTRUCTURE
4.4.2. DELAYED ADOPTION OF SINGLE CELL TECHNOLOGY
5. MARKET SEGMENTATION
5.1. BY APPLICATION
5.1.1. MEDICAL APPLICATIONS MARKET
5.1.1.1. CIRCULAR TUMOUR CELLS (CTCS) MARKET
5.1.1.2. NON-INVASIVE PRENATAL DIAGNOSIS MARKET
5.1.1.3. IN VITRO FERTILIZATION (IVF) MARKET
5.1.2. RESEARCH APPLICATIONS MARKET
5.1.2.1. CANCER MARKET
5.1.2.2. IMMUNOLOGY MARKET
5.1.2.3. NEUROLOGY MARKET
5.1.2.4. STEM CELLS MARKET
5.1.2.5. OTHER RESEARCH APPLICATIONS MARKET
5.2. BY TECHNIQUE
5.2.1. FLOW CYTOMETRY MARKET
5.2.2. MASS SPECTROMETRY MARKET
5.2.3. MICROSCOPY MARKET
5.2.3.1. NEXT-GENERATION SEQUENCING (NGS) MARKET
5.2.3.2. PCR (POLYMERASE CHAIN REACTION) MARKET
5.2.3.3. OTHER TECHNIQUES MARKET
5.3. BY CELL TYPE
5.3.1. ANIMAL CELLS MARKET
5.3.2. HUMAN CELLS MARKET
5.3.3. MICROBIAL CELLS MARKET
5.4. BY END USER
5.4.1. BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET
5.4.2. CELL BANKS AND IVF CENTERS MARKE
5.4.3. HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET
5.4.4. RESEARCH & ACADEMIC LABORATORIES MARKET
5.5. BY PRODUCT
5.5.1. CONSUMABLE MARKET
5.5.1.1. ASSAY KITS MARKET
5.5.1.2. BEADS MARKET
5.5.1.3. MICRO PLATES MARKET
5.5.1.4. REAGENTS MARKET
5.5.1.5. OTHER CONSUMABLES MARKET
5.5.2. INSTRUMENT MARKET
5.5.2.1. CELL COUNTER MARKET
5.5.2.2. CELL MICROARRAYS MARKET
5.5.2.3. FLOW CYTOMETERS MARKET
5.5.2.4. HCS SYSTEMS MARKET
5.5.2.5. MICROSCOPES
5.5.2.6. OTHER INSTRUMENTS
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCE MODEL
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCT
6.1.3. BARGAINING POWER OF BUYERS
6.1.4. BARGAINING POWER OF SUPPLIERS
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. OPPORTUNITY MATRIX
6.4. KEY BUYING CRITERIA
6.4.1. PRICING
6.4.2. EFFICACY
6.4.3. ACCURACY
6.4.4. APPLICATION AND EFFECTIVENESS
6.5. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.6. VENDOR LANDSCAPE
6.7. VALUE CHAIN ANALYSIS
7. REGIONAL ANALYSIS
7.1. ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET
7.1.1. INDIA SINGLE CELL ANALYSIS MARKET
7.1.2. CHINA SINGLE CELL ANALYSIS MARKET
7.1.3. JAPAN SINGLE CELL ANALYSIS MARKET
7.1.4. AUSTRALIA SINGLE CELL ANALYSIS MARKET
7.1.5. ROAPAC SINGLE CELL ANALYSIS MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.2. TOP WINNING STRATEGIES
9. COMPANY PROFILES
9.1. CORNING INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. CELGENE CORPORATION
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. ILLUMINA INC.
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVE
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. MILTENYI BIOTEC
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. STRATEGIC INITIATIVES
9.4.4. SCOT ANALYSIS
9.4.5. STRATEGIC ANALYSIS
9.5. NANOSTRING TECHNOLOGIESINC
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVE
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. AGILENT TECHNOLOGY INC
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. GE HEALTHCARE
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. BECKMAN COULTER, INC.
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. SCOT ANALYSIS
9.8.4. STRATEGIC ANALYSIS
9.9. MEDTRONIC’S PLC
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVE
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. STRYKER CORPORATION
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. THERMO FISHER SCIENTIFIC, INC.
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGIC INITIATIVE
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGIC ANALYSIS
9.12. QIAGEN N V
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT ANALYSIS
9.12.4. STRATEGIC ANALYSIS
9.13. BECKTON DICKINSON AND COMPANY
9.13.1. OVERVIEW
9.13.2. PRODUCT PORTFOLIO
9.13.3. SCOT ANALYSIS
9.13.4. STRATEGIC ANALYSIS
9.14. STEM CELL TECHNOLOGIES
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. STRATEGIC INITIATIVES
9.14.4. SCOT ANALYSIS
9.14.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY APPLICATION 2017-2025($ MILLION)
TABLE 2 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MEDICAL APPLICATIONS 2017-2025($ MILLION)
TABLE 3 ASIA-PACIFIC CTCS MARKET 2017-2025($ MILLION)
TABLE 4 ASIA-PACIFIC NIPT MARKET 2017-2025($ MILLION)
TABLE 5 ASIA-PACIFIC IVF MARKET 2017-2025($ MILLION)
TABLE 6 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS 2017-2025($ MILLION)
TABLE 7 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY RESEARCH APPLICATIONS 2017-2025($ MILLION)
TABLE 8 ASIA-PACIFIC CANCER MARKET 2017-2025($ MILLION)
TABLE 9 ASIA-PACIFIC IMMUNOLOGY MARKET 2017-2025($ MILLION)
TABLE 10 ASIA-PACIFIC NEUROLOGY MARKET 2017-2025($ MILLION)
TABLE 11 ASIA-PACIFIC STEM CELLS MARKET 2017-2025($ MILLION)
TABLE 12 ASIA-PACIFIC OTHER RESEARCH APPLICATIONS MARKET 2017-2025($ MILLION)
TABLE 13 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY TECHNIQUE 2017-2025($ MILLION)
TABLE 14 ASIA-PACIFIC FLOW CYTOMETRY MARKET 2017-2025($ MILLION)
TABLE 15 ASIA-PACIFIC MASS SPECTROMETRY MARKET 2017-2025($ MILLION)
TABLE 16 ASIA-PACIFIC MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 17 ASIA-PACIFIC MICROSCOPY MARKET 2017-2025($ MILLION)
TABLE 18 ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET 2017-2025($ MILLION)
TABLE 19 ASIA-PACIFIC PCR MARKET 2017-2025($ MILLION)
TABLE 20 ASIA-PACIFIC OTHER TECHNIQUES MARKET 2017-2025($ MILLION)
TABLE 21 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL TYPE 2017-2025($ MILLION)
TABLE 22 ASIA-PACIFIC ANIMAL CELL MARKET BY REGION 2017-2025($ MILLION)
TABLE 23 ASIA-PACIFIC HUMAN CELL MARKET 2017-2025($ MILLION)
TABLE 24 ASIA-PACIFIC MICROBIAL CELL MARKET 2017-2025($ MILLION)
TABLE 25 ASIA-PACIFIC BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
TABLE 26 ASIA-PACIFIC CELL BANKS AND IVF CENTERS MARKET 2017-2025($ MILLION)
TABLE 27 ASIA-PACIFIC HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 28 ASIA-PACIFIC RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
TABLE 29 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY PRODUCTS 2017-2025($ MILLION)
TABLE 30 ASIA-PACIFIC SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 31 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
TABLE 32 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
TABLE 33 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
TABLE 34 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY REAGENTS 2017-2025($ MILLION)
TABLE 35 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
TABLE 36 ASIA-PACIFIC SINGLE CELL ANALYSIS BY CONSUMABLE MARKET 2017-2025($ MILLION)
TABLE 37 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
TABLE 38 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
TABLE 39 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
TABLE 40 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
TABLE 41 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE LIST
FIGURE 1 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 2 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 3 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CTCS 2017-2025($ MILLION)
FIGURE 4 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY NIPT 2017-2025($ MILLION)
FIGURE 5 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY IVF 2017-2025($ MILLION)
FIGURE 6 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CANCER 2017-2025($ MILLION)
FIGURE 7 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY IMMUNOLOGY 2017-2025($ MILLION)
FIGURE 8 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY NEUROLOGY 2017-2025($ MILLION)
FIGURE 9 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY STEM CELLS 2017-2025($ MILLION)
FIGURE 10 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER RESEARCH APPLICATIONS 2017-2025($ MILLION)
FIGURE 11 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 12 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MASS SPECTROMETRY 2017-2025($ MILLION)
FIGURE 13 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROSCOPY 2017-2025($ MILLION)
FIGURE 14 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY NEXT GENERATION SEQUENCING 2017-2025($ MILLION)
FIGURE 15 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY PCR 2017-2025($ MILLION)
FIGURE 16 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER TECHNIQUES 2017-2025($ MILLION)
FIGURE 17 ASIA-PACIFIC ANIMAL CELL MARKET 2017-2025($ MILLION)
FIGURE 18 ASIA-PACIFIC HUMAN CELL MARKET 2017-2025($ MILLION)
FIGURE 19 ASIA-PACIFIC NEW CANCER CASES AND MOTILITY RATE IN MILLION (2015-2030)
FIGURE 20 ASIA-PACIFIC MICROBIAL CELL MARKET 2017-2025($ MILLION)
FIGURE 21 ASIA-PACIFIC BIOPHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET 2017-2025($ MILLION)
FIGURE 22 ASIA-PACIFIC CELL BANKS AND IVF CENTERS MARKET
FIGURE 23 ASIA-PACIFIC HOSPITALS AND DIAGNOSTICS LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 24 ASIA-PACIFIC RESEARCH & ACADEMIC LABORATORIES MARKET 2017-2025($ MILLION)
FIGURE 25 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY ASSAY KITS 2017-2025($ MILLION)
FIGURE 26 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY BEADS 2017-2025($ MILLION)
FIGURE 27 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROPLATES 2017-2025($ MILLION)
FIGURE 28 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY REGENTS 2017-2025($ MILLION)
FIGURE 29 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER CONSUMABLES 2017-2025($ MILLION)
FIGURE 30 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL COUNTER 2017-2025($ MILLION)
FIGURE 31 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY CELL MICROARRAY 2017-2025($ MILLION)
FIGURE 32 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY FLOW CYTOMETRY 2017-2025($ MILLION)
FIGURE 33 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY HCS SYSTEM 2017-2025($ MILLION)
FIGURE 34 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY MICROSCOPES 2017-2025($ MILLION)
FIGURE 35 ASIA-PACIFIC SINGLE CELL ANALYSIS MARKET BY OTHER INSTRUMENTS 2017-2025($ MILLION)
FIGURE 36 HEALTH REPORT OF INDIA ACCORDING 2015 SCENARIO
FIGURE 37 INDIAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 38 NUMBER OF CASES OF LUNG CANCERSTATISTICS IN CHINA (2010-2015)
FIGURE 39 CHINA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 40 JAPAN SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 41 ESTIMATED TB INCIDENCE BY AGE AND SEX (THOUSANDS), 2015 (AUSTRALIA)
FIGURE 42 AUSTRALIA SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
FIGURE 43 RO APAC SINGLE CELL ANALYSIS MARKET 2017-2025($ MILLION)
